Home>Topics>Stocks>Perrigo Company

Perrigo Company PRGO

  1. All
  2. Commentary
  3. Headlines
    1. Ultimate Stock-Pickers: 10 High-Conviction and New-Money Purchases

      Headlines

      Tue, 18 Nov 2014

      84 0.97 Medium 181,508 1 Perrigo PRGO 2 Narrow 154.46 1.29 Medium 20,548 ..... 54.1 1.2 Medium 139,882 1 Perrigo PRGO 2 Narrow 154.46 1.29 Medium 20,548 ..... Honeywell HON, Oracle ORCL, Perrigo PRGO , Hershey HSY, and Goldman Sachs GS

    2. A Shift in Health-Care M&A Activity

      Headlines

      Sat, 23 Aug 2014

      seen at least a half-dozen of them in the last 18 to 24 months--inversions like Actavis ACT and Warner Chilcott, Perrigo PRGO and Elan. And now, we're seeing it with the potential for the Pfizer and AstraZeneca deal. Conover : In some cases, the

    3. From Barron’s, March 24, 2014 (Part 2)

      Commentary

      Sat, 22 Mar 2014

      pharma. His picks are AGN, ESRX, ISRG, REGN, RHHBY ; also mentioned are BIIB, GILD, PCYC, MDVN, ALPMY, ABBV, JAZZ, PRGO , ACT, JNJ, BMY, MRK, A . Pg 30: Electronic investor analyses various portfolios and concludes that a 60-40 portfolio

    4. Here's Flakey's own iteration of the total stock market index

      Commentary

      Wed, 4 Sep 2013

      cyclical/2.322% in each CHD, FHCO, JJSF and VLGEA/consumer defensive/2.55% in each ATRI, GILD, IDXX, MLAB, NVO and PRGO /healthcare/2.147% in each ATNI/communication services/3.83%; and lastly CERN, CNQR, TYL/technology/5.51

    5. These eight stocks in an equally weighted portfolio gained 1000% over the last ten years

      Commentary

      Sun, 25 Aug 2013

      basis. They're not cheap but definitely worth a buy when they rarely tank. Here they are: DORM, EXPO, GILD, IT JBHT, PRGO TSCO, and WAB. Keep an eye on them; write those broker's checks when they correct and enjoy huge low volatility, low risk

    6. Perrigo Seeks Tax Advantage Through Acquisition of Elan

      Commentary

      Mon, 29 Jul 2013

      Perrigo PRGO announced that it will acquire Elan ELN in an $8.6 billion stock and cash deal, or $6.7 billion excluding Elan’s nearly

    7. Seasonal Factors, New Products, and Acquisitions Sustain Perrigo's High Growth

      Commentary

      Tue, 7 May 2013

      We’re leaving our $93 fair value estimate for Perrigo PRGO unchanged after the company reported fiscal-third quarter results mostly within our expectations. Management maintained its

    8. Using Aggressive Acquisition Strategy, Perrigo Snags Prescription Drug Deal

      Commentary

      Mon, 11 Feb 2013

      Perrigo PRGO announced that it will acquire Rosemont Pharmaceuticals, a leader in the U.K.’s oral liquid prescription drugs, for $283

    9. Perrigo Quickly Adds to Store-Brand Pet Health-Care Franchise

      Commentary

      Fri, 1 Feb 2013

      announcement to enter the retail pet health-care market through the acquisition of Sergeant's Pet Care Products, Perrigo PRGO now plans to expand its store-brand health-care franchise with the acquisition of Velcera in an all-cash $160 million

    10. Perrigo Achieves Margin Expansion Despite Mixed Quarter; Shares Still Look Overvalued

      Commentary

      Wed, 7 Nov 2012

      Perrigo's PRGO first-quarter results of 6% revenue and 15.5% non-GAAP EPS growth mostly matched our expectations. We're leaving our

    « Prev1234Next »
    Content Partners